[1] 傅亚, 刘灿, 欧启水. 乙型肝炎病毒感染的实验室诊断:现在与未来. 中华检验医学杂志,2020,43(9):849-854. [2] Kanda T, Goto T, Hirotsu Y, et al. Molecular nechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: A review. Int J Mol Sci,2019,20(6):1358-1381. [3] 王贵强, 王福生, 庄辉, 等. 慢性乙型肝炎防治指南(2019年版) 临床肝胆病杂志,2019,35(12):2648-2669. [4] Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol,2020,318(1):G84-G98. [5] Simon MC, Reinbeck AL, Wessel C, et al. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice. J Biol Chem,2020,295(4):969-980. [6] Ohtani N, Hara E. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Sci,2021,112(11):4433-4443. [7] 赵志方, 秦松, 王莉, 等. 慢性乙型肝炎患者肠道菌群与肝脏生化指标的相关性. 生物工程学报,2021,37(1):301-311. [8] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版).实用肝脏病杂志,2013,16(3):210-216. [9] 王维虎, 曾昭冲. 中国原发性肝细胞癌放射治疗指南(2020年版). 临床肝胆病杂志,2021,37(5):1029-1033. [10] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015).肝脏,2016,21(12):969-982. [11] 欧阳钦, 胡品津, 钱家鸣, 等. 对我国炎症性肠病诊断治疗规范的共识意见. 胃肠病学,2007,27(8):488-495. [12] Veracruz N, Gish RG, Cheung R, et al. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019. J Viral Hepat,2022,29(5):352-365. [13] Soriano V, Young B, Reau N. Report from the international conference on Viral Hepatitis - 2017. AIDS Rev,2018,20(1):58-70. [14] Sepanlou S, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol,2020,5(3):245-266. [15] Liu Y. Effect of intestinal microbiota imbalance associated with chronic hepatitisB virus infection on the expression of microRNA192 and GLP1. Mol Med Rep,2021,24(3):662-671. [16] Heidrich B, Vital M, Plumeier I, et al. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. Liver Int,2018,38(1):50-58. [17] Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol,2014,60(5):940-947. [18] Wang J, Wang Y, Zhang X, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol,2017,13(8):2222-2231. [19] 郑婷婷, 蒋珊珊, 方钟燎, 等. 慢性乙型肝炎、肝硬化和肝衰竭患者肠道菌群变化研究. 实用肝脏病杂志,2018,21(6):899-902. [20] 李攀. 肠道菌群的地理差异及其对疾病模型的影响. 南方医科大学,2018. [21] 邢乐康, 邓永东, 姚立琼, 等. 乙型肝炎肝硬化患者肠道菌群变化研究. 实用肝脏病杂志,2020,23(2):256-259. [22] Xu M, Wang B, Fu Y, et al. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb Ecol,2012,63(2):304-313. [23] Gerardo N, Debora C, Alba R. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol,2017,2(4):298-312. |